Home/Filings/4/0001127602-18-018570
4//SEC Filing

Ryding Neil Mr. 4

Accession 0001127602-18-018570

CIK 0000313143other

Filed

May 22, 8:00 PM ET

Accepted

May 23, 5:09 PM ET

Size

12.6 KB

Accession

0001127602-18-018570

Insider Transaction Report

Form 4
Period: 2016-10-20
Ryding Neil 122-62-507
EVP, Global Manufacturing
Transactions
  • Sale

    Common Stock

    2016-10-20$34.16/sh351$11,99019,325 total
  • Sale

    Common Stock

    2017-10-25$46.76/sh267$12,48515,409 total
  • Sale

    Common Stock

    2017-10-20$45.70/sh346$15,81215,676 total
  • Tax Payment

    Common Stock

    2017-01-13$40.32/sh3,303$133,17716,022 total
Footnotes (2)
  • [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
  • [F2]This number includes unvested restricted stock units previously reported.

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeother

Related Parties

1
  • filerCIK 0001654614

Filing Metadata

Form type
4
Filed
May 22, 8:00 PM ET
Accepted
May 23, 5:09 PM ET
Size
12.6 KB